Indications for: ORACEA

Treatment of only inflammatory lesions (papules and pustules) of rosacea.

Limitations of Use:

This formulation has not been evaluated in the treatment or prevention of infections. Not been evaluated for the treatment of erythematous, telangiectatic, or ocular components of rosacea.

Adult Dosage:

Take on empty stomach in the morning with sufficient amount of fluids. 40mg once daily.

Children Dosage:

Not recommended.

ORACEA Warnings/Precautions:

Do not substitute with other doxycycline products. Renal impairment. Hepatic insufficiency. Monitor blood, renal and hepatic function. Achlorhydria. GI surgery. Predisposition to candidiasis overgrowth. Avoid sun and UV light. Discontinue if superinfection occurs; treat appropriately. Monitor for autoimmune syndromes, visual disturbances. Labor & delivery. Pregnancy (during 2nd & 3rd trimester): avoid. Nursing mothers: not recommended (during and for 5 days after the last dose).

ORACEA Classification:

Tetracycline antibiotic.

ORACEA Interactions:

Avoid concomitant methoxyflurane, penicillins, photosensitizers, oral retinoids. Reduced absorption with bismuth subsalicylate, acid pump inhibitors, antacids, calcium, magnesium, iron. May potentiate anticoagulants (eg, warfarin). May antagonize hormonal contraceptives (use back-up contraception). May be antagonized by metabolic enzyme inducers (eg, barbiturates, carbamazepine, phenytoin).

Adverse Reactions:

Nasopharyngitis, sinusitis, superinfection, diarrhea, dry mouth, hypertension, blood glucose increase, elevated liver enzymes or BUN; C.difficile-associated diarrhea, autoimmune syndromes (discontinue if occurs), hyperpigmentation, photosensitivity, teeth discoloration, pseudotumor cerebri, others (see full labeling).

How Supplied: